Skip to main content
. 2013 Aug 7;44(4):385–392. doi: 10.1007/s12029-013-9532-4

Table 3.

Reintroduction of imatinib restores control of advanced GIST, but with a lower efficacy than the initial treatment [23]

Randomized to imatinib interruption (N = 51) CR rate (%) PR rate (%) SD rate (%)
Best response prior to imatinib interruption 33.3 49 17.6
Best response following imatinib reintroduction (relative to responding patients) 41.2 56 NR
Best response following imatinib reintroduction (relative to total patients) 13.7 27.5 NR

CR complete response, NR not reported, PR partial response, SD stable disease